1.
|
A JemalR SiegelE WardY HaoJ XuT MurrayMJ
ThunCancer statistics, 2008CA Cancer J
Clin587196200810.3322/CA.2007.0010
|
2.
|
SV SharmaDW BellJ SettlemanDA
HaberEpidermal growth factor receptor mutations in lung cancerNat
Rev Cancer7169181200710.1038/nrc208817318210
|
3.
|
T SantariusJ ShipleyD BrewerMR StrattonCS
CooperA census of amplified and overexpressed human cancer genesNat
Rev Cancer105964201010.1038/nrc277120029424
|
4.
|
L ChenZ LiangQ TianOverexpression of LCMR1
is significantly associated with clinical stage in human NSCLCJ Exp
Clin Cancer Res3018201110.1186/1756-9966-30-1821306606
|
5.
|
S SatoC Tomomori-SatoTJ ParmelyA set of
consensus mammalian mediator subunits identified by
multidimensional protein identification technologyMol
Cell14685691200410.1016/j.molcel.2004.05.006
|
6.
|
E Ji-FuJJ XingLQ HaoCG FuSuppression of
lung cancer metastasis-related protein 1 (LCMR1) inhibits the
growth of colorectal cancer cellsMol Biol
Rep3936753681201210.1007/s11033-011-1142-221732059
|
7.
|
M SunR JiangJD LiMED19 promotes
proliferation and tumorigenesis of lung cancerMol Cell
Biochem3552733201110.1007/s11010-011-0835-021519921
|
8.
|
SW ZouKX AiZG WangZ YuanJ YanQ ZhengThe
role of Med19 in the proliferation and tumorigenesis of human
hepatocellular carcinoma cellsActa Pharmacol
Sin32354360201110.1038/aps.2010.22321372827
|
9.
|
DA LiebermannB HoffmanRA SteinmanMolecular
controls of growth arrest and apoptosis: p53-dependent and
independent pathwaysOncogene1119921019957624128
|
10.
|
A BasuS HaldarThe relationship between
BcI2, Bax and p53: consequences for cell cycle progression and cell
deathMol Hum Reprod410991109199810.1093/molehr/4.12.10999872359
|
11.
|
GI EvanKH VousdenProliferation, cell cycle
and apoptosis in
cancerNature411342348200110.1038/3507721311357141
|
12.
|
J MatternM VolmImbalance of cell
proliferation and apoptosis during progression of lung
carcinomasAnticancer Res2442434246200415736479
|
13.
|
WM CongA BakkerPA SwalskyMultiple genetic
alterations involved in the tumorigenesis of human
cholangiocarcinoma: a molecular genetic and clinicopathological
studyJ Cancer Res Clin
Oncol127187192200110.1007/s00432000019411260864
|
14.
|
TM GottliebM Orenp53 and apoptosisSemin
Cancer Biol8359368199810.1006/scbi.1998.0098
|
15.
|
JD AmaralJM XavierCJ SteerCM RodriguesThe
role of p53 in apoptosisDiscov Med91451522010
|
16.
|
JS FridmanSW LoweControl of apoptosis by
p53Oncogene2290309040200310.1038/sj.onc.120711614663481
|
17.
|
NN DanialBCL-2 family proteins: critical
checkpoints of apoptotic cell deathClin Cancer
Res1372547263200710.1158/1078-0432.CCR-07-159818094405
|
18.
|
RW CraigThe bcl-2 gene familySemin Cancer
Biol6354319957548840
|
19.
|
JE ChipukT KuwanaL Bouchier-HayesNM
DroinDD NewmeyerM SchulerDR GreenDirect activation of Bax by p53
mediates mitochondrial membrane permeabilization and
apoptosisScience30310101014200410.1126/science.109273414963330
|
20.
|
B AntonssonS MontessuitS LauperR EskesJC
MartinouBax oligomerization is required for channel-forming
activity in liposomes and to trigger cytochrome c release from
mitochondriaBiochem
J345271278200010.1042/0264-6021:345027110620504
|
21.
|
LW ThomasC LamSW EdwardsMcl-1; the
molecular regulation of protein functionFEBS
Lett58429812989201010.1016/j.febslet.2010.05.06120540941
|
22.
|
S SomeyaJ XuK KondoAge-related hearing
loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial
apoptosisProc Natl Acad Sci
USA1061943219437200910.1073/pnas.090878610619901338
|